Investigation of linezolid resistance in Staphylococcus epidermidis: first reported linezolid resistant coagulase negative staphylococcus in Turkey*

References (14)

1. Swaney SM, Aoki H, Ganoza MC, Shinabarger DL. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother 1998; 42: 3251– 3255
2. Laursen BS, Sørensen HP, Mortensen KK, Sperling-Petersen HU. Initiation of protein synthesis in bacteria. Microbiol Mol Biol Rev 2005; 69: 101–123
3. Livermore DM. Linezolid in vitro mechanism and antibacterial spectrum. J Antimicrob Chemother 2003; 51: ii9–ii16
4. Kloss PL, Xiong DL, Mankin AS. Resistance mutations in 23S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center. J Mol Biol 1999; 294: 93–101
5. Wong A, Reddy SP, Smyth DS, Aguero-Rosenfeld ME, Sakoulas G, Robinson DA. Polyphyletic emergence of linezolid-resistant Staphylococci in the United States. Antimicrob Agents Chemother 2010; 54: 742–748
6. Long KS, Poehlsgaard J, Kehrenberg C, Schwarz S, Vester B. The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics. Antimicrob Agents Chemother 2006; 50: 2500–2505
7. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing, Approved standard M100-S20. 20th edition. Wayne, PA, USA; 2010
8. Hong T, Xiangyang L, Wang J, Sloan C, Cicogna C. Sequential linezolid-resistant Staphylococcus epidermidis isolates with G2576T mutation. J Clin Microbiol 2007; 45: 3277–3280
9. Vardakas KZ, Kioumis I, Falagas ME. Association of pharmacokinetic and pharmacodynamic aspects of linezolid with infection outcome. Curr Drug Metab 2009; 10: 2–12
10. Falagas ME, Siempos II, Vardakas KZ. Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials. Lancet Infect Dis 2008; 8: 53–66
11. Stefani S, Bongiorno D, Mongelli G, Campanile F. Linezolid resistance in Staphylococci. Pharmaceuticals 2010; 1988–2006
12. Afşar I, Barış I, Şener AG, Köksal V, Demirci M. Linezolidresistant Enterococcus faecium: the first G2576T mutation in Turkey. Mikrobiyol Bul 2012; 46: 516–518
13. Baos E, Candel FJ, Merino P, Pena I, Picazzo JJ. Characterization and monitoring of linezolid-resistant clinical isolates of Staphylococcus epidermidis in an intensive care unit 4 years after an outbreak of infection by cfr-mediated linezolidresistant Staphylococcus aureus. Diagn Microbiol Infect Dis 2013; 76: 325–329
14. Ağalar C, Göçm